首页> 外文期刊>Journal of Medicinal Chemistry >Alkyl-Substituted Polyaminohydroxamic Acids: A Novel Class of Targeted Histone Deacetylase Inhibitors
【24h】

Alkyl-Substituted Polyaminohydroxamic Acids: A Novel Class of Targeted Histone Deacetylase Inhibitors

机译:烷基取代的聚氨基异羟肟酸:新型的靶向组蛋白脱乙酰基酶抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

The reversible acetylation of histones is critical for regulation of eukaryotic gene expression.The histone deacetylase inhibitors trichostatin (TSA,1),MS-275 (2) and suberoylanilide hydroxamic acid (SAHA,3) arrest growth in transformed cells and in human tumor xenografts.However,1-3 suffer from lack of specificity among the various HDAC isoforms,prompting us to design and synthesize polyaminohydroxamic acid (PAHA) derivatives 6-21.We felt that PAHAs would be selectively directed to chromatin and associated histones by the positively charged polyamine side chain.At 1muM,compounds 12,15 and 20 inhibited HDAC by 74.86,59.99 and 73.85%,respectively.Although 20 was a less potent HDAC inhibitor than 1,it was more potent than 2,more effective as an initiator of histone hyperacetylation,and significantly more effective than 2 at re-expressing p21~(Waf1) in ML-1 leukemia cells.On the basis of these results,PAHAs 6-21 represent an important new chemical class of HDAC inhibitors.
机译:组蛋白的可逆乙酰化对于调节真核基因表达至关重要。组蛋白脱乙酰基酶抑制剂曲古抑素(TSA,1),MS-275(2)和亚磺酰苯胺异羟肟酸(SAHA,3)阻止转化细胞和人肿瘤异种移植物中的生长。然而,1-3受各种HDAC同工型缺乏特异性的困扰,促使我们设计和合成聚氨基异羟肟酸(PAHA)衍生物6-21。我们认为,带正电的PAHAs可以选择性地针对染色质和相关的组蛋白。在1μM时,化合物12,15和20分别抑制HDAC 74.86,59.99和73.85%。尽管20是HDAC抑制剂的效力不及1,但比2更有效,作为组蛋白引发剂更有效高乙酰化作用,并且在ML-1白血病细胞中重新表达p21〜(Waf1)的效力明显高于2。基于这些结果,PAHA 6-21代表了HDAC抑制剂的重要化学新类别。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号